OTC Markets EXMKT - Delayed Quote USD
Item 9 Labs Corp. (INLB)
At close: October 21 at 4:00 PM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Robert E. Mikkelsen | Secretary, Treasurer & CFO | 263.68k | -- | 1982 |
| Mr. Christopher Leland Wolven | Chief Operating Officer | 256.45k | -- | 1983 |
| Mr. Jeffrey I. Rassas | Strategic Advisor & Director | 176.58k | -- | 1963 |
| Ms. Jayne Levy | Senior Vice President of Communications | -- | -- | -- |
| Kyle Jennings | Vice President of Marketing | -- | -- | -- |
| Mr. Mark Busch | Senior Vice President of Corporate Development | -- | -- | -- |
| Mr. Cory Carter | Senior Vice President of Cultivation | -- | -- | -- |
Item 9 Labs Corp.
2727 North 3rd Street
Suite 201
Phoenix, AZ 85004
United States
- Sector:?
- Healthcare
- Industry:? Drug Manufacturers - Specialty & Generic
- Full Time Employees:?
- 97
Description
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Corporate Governance
Item 9 Labs Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
October 21, 2024 at 8:00 PM UTC - October 27, 2024 at 8:00 PM UTC
Item 9 Labs Corp. Earnings Date
Recent Events
Related Tickers
VDQSF Gnomestar Craft Inc.
0.0012
0.00%
LRSNF Global Health Clinics Ltd.
0.0011
0.00%
BIOIF Biome Grow Inc.
0.0037
0.00%
AGYTF Allergy Therapeutics plc
0.0600
0.00%
NXGB NxGen Brands Inc.
0.0002
0.00%
NXEN Nexien BioPharma, Inc.
0.0480
+150.00%
GGBXF Green Growth Brands Inc.
0.0000
0.00%
GBHPF Global Hemp Group Inc.
0.0150
0.00%
TMSH TransGlobal Assets Inc.
0.0003
+25.00%
CVSI CV Sciences, Inc.
0.0500
+3.09%